Azalea Therapeutics vs Tome Biosciences
Azalea Therapeutics
Redefining precision genomic medicines, in vivo
31 employees · est. 2023 · Berkeley, United States
Tome Biosciences
The final chapter in genomic medicine
142 employees · est. 2021 · Watertown, United States
Tome Biosciences is the older company (2023 vs 2021); Tome Biosciences is the larger of the two.
Side-by-Side Comparison
| Metric | Azalea Therapeutics | Tome Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2023 | 2021 older |
| Headquarters | ||
| Headquarters | Berkeley, United States | Watertown, United States |
| Employees | ||
| Employees | 31 | 142 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series A | Series A |
| Total Funding | ||
| Total Funding | $82.00M | $213.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | In Vivo Precision Genome Engineering, Cancer Immunotherapy Development, Genome Editing Platform | facilitating domain purchases, providing domain insights, daily domain data updates, searchable domain database, SEO score analysis, third-party registrar connection |
| Target Customers | ||
| Target Customers | Cancer Patients, Medical Researchers, Biotech Investors | digital marketers, SEO specialists, domain investors, startups, brand managers, web developers |
| Taxonomy | ||
| Taxonomy | Precision Genomic MedicinesCRISPR-Cas9Genome EditingEnveloped Delivery VehiclesIn Vivo TherapiesCAR-T Cell Therapies +8 | Genomic MedicineProgrammable Genomic IntegrationGene TherapiesIntegrative Gene TherapiesCRISPR TechnologyGene Insertion +4 |
| Website | ||
| Website | azaleatx.com | tome.bio |
About Azalea Therapeutics
Azalea Therapeutics, founded in 2023, is a pioneering player in the biotechnology sector, committed to transforming the landscape of precision genomic medicines in vivo. With its bold slogan—Redefining precision genomic medicines, in vivo—the company underscores its focus on groundbreaking genetic t...
About Tome Biosciences
Tome Biosciences, founded in 2021 and headquartered in the United States, is pioneering advancements in the Biotechnology sector. Under its slogan, "The final chapter in genomic medicine," the company leverages innovative programmable genomic integration (PGI) technology that facilitates the precise...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Azalea Therapeutics and Tome Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Azalea Therapeutics or Tome Biosciences moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Azalea Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Azalea Therapeutics on 9 Jun 2026, and Tome Biosciences on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
